• Find People
  • Campus Map
  • PiratePort
  • A-Z
    • About
    • Submit
    • Browse
    • Login
    View Item 
    •   ScholarShip Home
    • Division of Health Sciences
    • Brody School of Medicine
    • Microbiology and Immunology
    • View Item
    •   ScholarShip Home
    • Division of Health Sciences
    • Brody School of Medicine
    • Microbiology and Immunology
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of The ScholarShipCommunities & CollectionsDateAuthorsTitlesSubjectsTypeDate SubmittedThis CollectionDateAuthorsTitlesSubjectsTypeDate Submitted

    My Account

    Login

    Statistics

    View Google Analytics Statistics

    PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer

    Thumbnail
    View/ Open
    McCubreyPTENStatusisaCrucialDeterminantoftheFunctionalOutcome.pdf (2.223Mb)

    Show full item record
    
    Author
    McCubrey, James A.
    URI
    http://hdl.handle.net/10342/9643
    Subject
     PTEN; MEK and mTOR inhibition; cancer 
    Date
    2017-02-21
    Citation:
    APA:
    McCubrey, James A.. (February 2017). PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer. Scientific Reports, (43013. Retrieved from http://hdl.handle.net/10342/9643

    Display/Hide MLA, Chicago and APA citation formats.

    MLA:
    McCubrey, James A.. "PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer". Scientific Reports. . (43013.), February 2017. May 17, 2022. http://hdl.handle.net/10342/9643.
    Chicago:
    McCubrey, James A., "PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer," Scientific Reports 7, no. (February 2017), http://hdl.handle.net/10342/9643 (accessed May 17, 2022).
    AMA:
    McCubrey, James A.. PTEN status is a crucial determinant of the functional outcome of combined MEK and mTOR inhibition in cancer. Scientific Reports. February 2017; 7() 43013. http://hdl.handle.net/10342/9643. Accessed May 17, 2022.
    Collections
    • Microbiology and Immunology

    xmlui.ArtifactBrowser.ItemViewer.elsevier_entitlement

    East Carolina University has created ScholarShip, a digital archive for the scholarly output of the ECU community.

    • About
    • Contact Us
    • Send Feedback